Ultra-stable zeolites -: a tool for in-cell chemistry

被引:24
作者
Dahm, Å [1 ]
Eriksson, H [1 ]
机构
[1] Malmo Univ, S-20506 Malmo, Sweden
关键词
adsorption; endosomal pathway; phagocytosing cells; release; ultra-stable zeolite;
D O I
10.1016/j.jbiotec.2004.04.008
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Ultrastable zeolite particles were used as vehicles to carry low molecular bio-active substances and macromolecules as proteins into viable cells. Zeolite particles that can be used for internalisation by phagocytosis were obtained from the non-sedimenting fraction of a commercially available zeolite preparation after 1 x g sedimentation. Protein adsorbed on the zeolite surface was shown to enter the endosomal pathway after phagocytosis and could be cleaved by the endosomal proteases. As a model of a low molecular weight bio-active molecule, the inhibitor of the cellular synthesis of nitrogen oxide, N-nitro-L-arginine methyl ester (L-NAME), was used. A partial inhibition of the cellular NO production was shown after utilizing zeolites as vehicles to introduce the inhibitor into the cells. A targeting of the intra-cellular enzymes that was at least 10 times more efficient was obtained by the use of zeolites as a carrier of the inhibitor, as opposed to addition of the inhibitor to the culture medium. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:279 / 290
页数:12
相关论文
共 14 条
[1]  
Boyum A., 1968, SCAND J CLIN LAB INV, V21, P97
[2]  
Breck D.W, 1974, ZEOLITE MOL SIEVES
[3]  
BURKHARD H, 2000, BIOCHEM BIOPH RES CO, V271, P353
[4]   Removal of toxic preservatives in pharmaceutical preparations of insulin by the use of ultra-stable zeolite Y [J].
Eriksson, H .
BIOTECHNOLOGY TECHNIQUES, 1998, 12 (04) :329-334
[5]  
ERIKSSON H, 1992, BIOTECHNOL TECH, V6, P239
[6]   Conditions for the adsorption of proteins on ultrastable zeolite Y and its use in protein purification [J].
Klint, D ;
Eriksson, H .
PROTEIN EXPRESSION AND PURIFICATION, 1997, 10 (02) :247-255
[7]   Nanotechnology: R&D challenges and opportunities for application in biotechnology [J].
Laval, JM ;
Chopineau, J ;
Thomas, D .
TRENDS IN BIOTECHNOLOGY, 1995, 13 (11) :474-481
[8]   MHC class I- and class II-restricted processing and presentation of microencapsulated antigens [J].
Men, Y ;
Audran, R ;
Thomasin, C ;
Eberl, G ;
Demotz, S ;
Merkle, HP ;
Gander, B ;
Corradin, G .
VACCINE, 1999, 17 (9-10) :1047-1056
[10]   FUNCTIONAL MACROPHAGE CELL LINES TRANSFORMED BY ABELSON LEUKEMIA-VIRUS [J].
RASCHKE, WC ;
BAIRD, S ;
RALPH, P ;
NAKOINZ, I .
CELL, 1978, 15 (01) :261-267